The United Nations Children’s Fund (UNICEF) has launched an emergency tender to secure monkeypox vaccines for crisis-affected countries, in collaboration with GAVI, the Vaccine Alliance, the Centers for Disease Control and Prevention (CDC) in Africa, and the World Health Organization (WHO).

A joint statement from the organizations mentioned that agreements could be made for up to 12 million doses by 2025, depending on manufacturers’ production capacity.

According to the statement reported by Reuters, UNICEF will establish conditional supply agreements with vaccine manufacturers under the tender. This will allow the organization to purchase and ship vaccines without delay once funding, demand, readiness, and regulatory requirements are confirmed.

The collaboration, which also involves working with GAVI, the Pan American Health Organization (PAHO), the Global Alliance for Vaccines and Immunization (GAVI), the CDC in Africa, and the WHO, aims to facilitate the donation of vaccines from current stocks in high-income countries.

The statement added that the WHO is reviewing the information provided by manufacturers as of August 23 and expects to complete the emergency use listing review by mid-September.